News

Filter

Current filters:

Lialda

1 to 9 of 63 results

Shire posts top year-end results and expects earnings to rise again in 2014

Shire posts top year-end results and expects earnings to rise again in 2014

13-02-2014

Ireland-headquartered drugmaker Shire has recorded a rise in sales and earnings to deliver strong full-year…

DermagraftFinancialFirazyrIntunivLialdaMezavantNorthern EuropePharmaceuticalShireViroPharmaVprivVyvanse

Shire prevails in US Lialda patent dispute with Watson

10-05-2013

Ireland-headquartered drugmaker Shire's (LSE: SHP) subsidiary Shire Development has prevailed in its…

ActavisGastro-intestinalsGenericsLegalLialdaNorth AmericaPatentsPharmaceuticalShireWatson Pharmaceuticals

Shire takes hit as bowel disease drug Lialda fails in Ph III trial

02-04-2012

The shares of Ireland-headquartered Shire (LSE: SHP) dropped 4.9% to £20.14 in mid afternoon trading…

Gastro-intestinalsLialdaMesalaminePharmaceuticalResearchShire

Shire’s Lialda now OKed for ulcerative colitis maintenance of remission in the USA

19-07-2011

The US Food and Drug Administration has approved Ireland-headquartered specialty drugmaker Shire’s…

Gastro-intestinalsLialdaNorth AmericaPharmaceuticalRegulationShire

Shire files suit against Cadila/Zydus Cadila for Lialda patent infringement

09-07-2010

Ireland-based Shire has filed a law suit in the US District Court for the District of Delaware against…

Cadila PharmaceuticalsGastro-intestinalsGenericsLegalLialdaNorth AmericaPatentsPharmaceuticalShireZydus Cadila

Zydus tells Shire it has filed US ANDA for ulcerative colitis drug Lialda

01-06-2010

Ireland-headquartered Shire says that it has received a Paragraph IV Notice Letter from Zydus Pharmaceuticals…

Gastro-intestinalsGenericsLialdaNorth AmericaPatentsPharmaceuticalRegulationShireZydus Cadila

1 to 9 of 63 results

COMPANY SPOTLIGHT

Menarini

Back to top